FCHI8,141.92-0.19%
GDAXI24,083.53-0.19%
DJI49,167.79-0.13%
XLE56.900.23%
STOXX50E5,860.32-0.39%
XLF51.810.76%
FTSE10,321.09-0.56%
IXIC24,887.100.20%
RUT2,788.190.04%
GSPC7,173.910.12%
Temp27°C
UV0
Feels29.4°C
Humidity72%
Wind10.8 km/h
Air QualityAQI 1
Cloud Cover19%
Rain0%
Sunrise06:00 AM
Sunset06:47 PM
Time7:39 PM
VCYTNGMHealthcare·Diagnostics & Research#22 in industry

Veracyte, Inc.

Reports in 8d· 2026-05-05
$33.85
-0.48 (-1.40%)

News

(2)

April 2026

6 days agoARSHealthcare

Please provide the actual SEC filing content for the headline to be generated. The current input is a request for information, not a summary of a filing

VCYTVERACYTE, INC.

I apologize, but the content for the SEC filing for Veracyte, Inc. (VCYT) was not included in the request. The input provided only contained the document metadata but no actual text, PDF, or narrative content. As an expert financial analyst, I need the document's content to provide the comprehensiv

Read summaryView on SEC EDGAR
6 days agoDEF 14AHealthcare

VCYT seeks shareholder vote approving 3.5 million shares for equity plan

VCYTVERACYTE, INC.

# 📜 What This Document Is ℹ️ This is a Definitive Proxy Statement (a DEF 14A), which is a highly formal document filed with the SEC that tells shareholders exactly what decisions they will be voting on at the company's Annual Meeting. Think of it as a "playbook" for the annual meeting, outlining th

Read summaryView on SEC EDGAR

Peers in Diagnostics & Research